Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome
Standard
Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome. / Rao, Jia; Ashraf, Shazia; Tan, Weizhen; van der Ven, Amelie T; Gee, Heon Yung; Braun, Daniela A; Fehér, Krisztina; George, Sudeep P; Esmaeilniakooshkghazi, Amin; Choi, Won-Il; Jobst-Schwan, Tilman; Schneider, Ronen; Schmidt, Johanna Magdalena; Widmeier, Eugen; Warejko, Jillian K; Hermle, Tobias; Schapiro, David; Lovric, Svjetlana; Shril, Shirlee; Daga, Ankana; Nayir, Ahmet; Shenoy, Mohan; Tse, Yincent; Bald, Martin; Helmchen, Udo; Mir, Sevgi; Berdeli, Afig; Kari, Jameela A; El Desoky, Sherif; Soliman, Neveen A; Bagga, Arvind; Mane, Shrikant; Jairajpuri, Mohamad A; Lifton, Richard P; Khurana, Seema; Martins, Jose C; Hildebrandt, Friedhelm.
in: J CLIN INVEST, Jahrgang 127, Nr. 12, 01.12.2017, S. 4257-4269.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome
AU - Rao, Jia
AU - Ashraf, Shazia
AU - Tan, Weizhen
AU - van der Ven, Amelie T
AU - Gee, Heon Yung
AU - Braun, Daniela A
AU - Fehér, Krisztina
AU - George, Sudeep P
AU - Esmaeilniakooshkghazi, Amin
AU - Choi, Won-Il
AU - Jobst-Schwan, Tilman
AU - Schneider, Ronen
AU - Schmidt, Johanna Magdalena
AU - Widmeier, Eugen
AU - Warejko, Jillian K
AU - Hermle, Tobias
AU - Schapiro, David
AU - Lovric, Svjetlana
AU - Shril, Shirlee
AU - Daga, Ankana
AU - Nayir, Ahmet
AU - Shenoy, Mohan
AU - Tse, Yincent
AU - Bald, Martin
AU - Helmchen, Udo
AU - Mir, Sevgi
AU - Berdeli, Afig
AU - Kari, Jameela A
AU - El Desoky, Sherif
AU - Soliman, Neveen A
AU - Bagga, Arvind
AU - Mane, Shrikant
AU - Jairajpuri, Mohamad A
AU - Lifton, Richard P
AU - Khurana, Seema
AU - Martins, Jose C
AU - Hildebrandt, Friedhelm
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of chronic kidney disease. Here, we identified recessive mutations in the gene encoding the actin-binding protein advillin (AVIL) in 3 unrelated families with SRNS. While all AVIL mutations resulted in a marked loss of its actin-bundling ability, truncation of AVIL also disrupted colocalization with F-actin, thereby leading to impaired actin binding and severing. Additionally, AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex. Knockdown of AVIL in human podocytes reduced actin stress fibers at the cell periphery, prevented recruitment of PLCE1 to the ARP3-rich lamellipodia, blocked EGF-induced generation of diacylglycerol (DAG) by PLCE1, and attenuated the podocyte migration rate (PMR). These effects were reversed by overexpression of WT AVIL but not by overexpression of any of the 3 patient-derived AVIL mutants. The PMR was increased by overexpression of WT Avil or PLCE1, or by EGF stimulation; however, this increased PMR was ameliorated by inhibition of the ARP2/3 complex, indicating that ARP-dependent lamellipodia formation occurs downstream of AVIL and PLCE1 function. Together, these results delineate a comprehensive pathogenic axis of SRNS that integrates loss of AVIL function with alterations in the action of PLCE1, an established SRNS protein.
AB - Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of chronic kidney disease. Here, we identified recessive mutations in the gene encoding the actin-binding protein advillin (AVIL) in 3 unrelated families with SRNS. While all AVIL mutations resulted in a marked loss of its actin-bundling ability, truncation of AVIL also disrupted colocalization with F-actin, thereby leading to impaired actin binding and severing. Additionally, AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex. Knockdown of AVIL in human podocytes reduced actin stress fibers at the cell periphery, prevented recruitment of PLCE1 to the ARP3-rich lamellipodia, blocked EGF-induced generation of diacylglycerol (DAG) by PLCE1, and attenuated the podocyte migration rate (PMR). These effects were reversed by overexpression of WT AVIL but not by overexpression of any of the 3 patient-derived AVIL mutants. The PMR was increased by overexpression of WT Avil or PLCE1, or by EGF stimulation; however, this increased PMR was ameliorated by inhibition of the ARP2/3 complex, indicating that ARP-dependent lamellipodia formation occurs downstream of AVIL and PLCE1 function. Together, these results delineate a comprehensive pathogenic axis of SRNS that integrates loss of AVIL function with alterations in the action of PLCE1, an established SRNS protein.
KW - Actin-Related Protein 2-3 Complex/genetics
KW - Cell Movement/genetics
KW - Diglycerides/genetics
KW - Female
KW - Humans
KW - Male
KW - Microfilament Proteins/genetics
KW - Mutation
KW - Nephrotic Syndrome/congenital
KW - Phosphoinositide Phospholipase C/genetics
KW - Podocytes/metabolism
KW - Pseudopodia/genetics
U2 - 10.1172/JCI94138
DO - 10.1172/JCI94138
M3 - SCORING: Journal article
C2 - 29058690
VL - 127
SP - 4257
EP - 4269
JO - J CLIN INVEST
JF - J CLIN INVEST
SN - 0021-9738
IS - 12
ER -